Martha Werler - Publications

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Public Health, Health Care Management

98 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Papadopoulos EA, Howley MM, Fisher SC, Van Zutphen AR, Werler MM, Romitti PA, Browne ML. Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997-2011. Pharmacoepidemiology and Drug Safety. PMID 38112229 DOI: 10.1002/pds.5741  0.384
2023 Neo DT, Martin CL, Carmichael SL, Gucsavas-Calikoglu M, Conway KM, Evans SP, Feldkamp ML, Gilboa SM, Insaf TZ, Musfee FI, Shaw GM, Shumate C, Werler MM, Olshan AF, Desrosiers TA. Are individual-level risk factors for gastroschisis modified by neighborhood-level socioeconomic factors? Birth Defects Research. PMID 37439400 DOI: 10.1002/bdr2.2224  0.309
2023 Werler MM, Kerr SM, Ailes EC, Reefhuis J, Gilboa SM, Browne ML, Kelley KE, Hernandez-Diaz S, Smith-Webb RS, Huezo Garcia M, Mitchell AA. Patterns of prescription medication use during the first trimester of pregnancy in the United States, 1997-2018. Clinical Pharmacology and Therapeutics. PMID 37356083 DOI: 10.1002/cpt.2981  0.307
2023 Howley MM, Werler MM, Fisher SC, Tracy M, Van Zutphen AR, Papadopoulos EA, Hansen C, Ailes EC, Reefhuis J, Wood ME, Browne ML. Maternal exposure to zolpidem and risk of specific birth defects. Journal of Sleep Research. e13958. PMID 37269133 DOI: 10.1111/jsr.13958  0.401
2023 Neo DT, Desrosiers TA, Martin CL, Carmichael SL, Gucsavas-Calikoglu M, Conway KM, Evans SP, Feldkamp ML, Gilboa SM, Insaf TZ, Musfee FI, Shaw GM, Shumate CJ, Werler MM, Olshan AF. Neighborhood-level socioeconomic position during early pregnancy and risk of gastroschisis. Epidemiology (Cambridge, Mass.). PMID 36976718 DOI: 10.1097/EDE.0000000000001621  0.381
2023 Petersen JM, Hutcheon JA, Bodnar LM, Parker SE, Ahrens KA, Werler MM. Weight gain patterns among pregnancies with obesity and small- and large-for-gestational-age births. Obesity (Silver Spring, Md.). 31: 1133-1145. PMID 36942419 DOI: 10.1002/oby.23693  0.551
2022 Petersen JM, Parker SE, Dukes KA, Hutcheon JA, Ahrens KA, Werler MM. Machine learning-based placental clusters and their associations with adverse pregnancy outcomes. Paediatric and Perinatal Epidemiology. PMID 36441121 DOI: 10.1111/ppe.12938  0.542
2022 Schrager NL, Parker SE, Werler MM. The association of nausea and vomiting of pregnancy, its treatments, and select birth defects: Findings from the National Birth Defect Prevention Study. Birth Defects Research. PMID 36168701 DOI: 10.1002/bdr2.2096  0.348
2022 García MH, Petersen JM, Parker SE, Rubenstein E, Werler MM. Medication use during pregnancy among women with congenital physical disabilities. Birth Defects Research. PMID 35652163 DOI: 10.1002/bdr2.2048  0.306
2022 Kerr S, Heinke D, Yazdy MM, Mitchell AA, Darling AM, Lin A, Nestoridi E, Werler MM. Use of vasoactive medications in pregnancy and the risk of stillbirth among birth defect cases. Birth Defects Research. PMID 35238183 DOI: 10.1002/bdr2.1996  0.433
2021 Howley MM, Werler MM, Fisher SC, Van Zutphen AR, Carmichael SL, Broussard CS, Heinke D, Ailes EC, Pruitt SM, Reefhuis J, Mitchell AA, Browne ML. Maternal exposure to hydroxychloroquine and birth defects. Birth Defects Research. PMID 34296811 DOI: 10.1002/bdr2.1943  0.367
2021 Esposito DB, Bateman B, Werler M, Straub L, Mogun H, Hernandez-Diaz S, Huybrechts K. Ischemic Placental Disease, Preterm Delivery, and their Association with Opioid Use During Pregnancy. American Journal of Epidemiology. PMID 34165143 DOI: 10.1093/aje/kwab132  0.394
2021 Petersen JM, Yazdy MM, Getz KD, Anderka MT, Werler MM. Short interpregnancy intervals and risks for birth defects: support for the nutritional depletion hypothesis. The American Journal of Clinical Nutrition. PMID 33668063 DOI: 10.1093/ajcn/nqaa436  0.332
2021 Brogly SB, Velez MP, Werler MM, Li W, Camden A, Guttmann A. Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes. Epidemiology (Cambridge, Mass.). 32: 448-456. PMID 33625160 DOI: 10.1097/EDE.0000000000001328  0.363
2020 Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM. Folic acid antagonist use before and during pregnancy and risk for selected birth defects. Birth Defects Research. PMID 32875745 DOI: 10.1002/Bdr2.1789  0.363
2020 Hansen C, Desrosiers TA, Wisniewski K, Strickland MJ, Werler MM, Gilboa SM. Use of antihistamine medications during early pregnancy and selected birth defects: The National Birth Defects Prevention Study, 1997-2011. Birth Defects Research. PMID 32657014 DOI: 10.1002/Bdr2.1749  0.405
2020 Schrager NL, Adrien N, Werler MM, Parker SE, Van Bennekom C, Mitchell AA. Trends in first-trimester nausea and vomiting of pregnancy and use of select treatments: Findings from the National Birth Defects Prevention Study. Paediatric and Perinatal Epidemiology. PMID 32623767 DOI: 10.1111/ppe.12705  0.356
2020 Petersen JM, Esposito DB, Werler MM. Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014). Archives of Women's Mental Health. PMID 32222834 DOI: 10.1007/s00737-020-01027-x  0.331
2019 Parker SE, Collett BR, Werler MM. Maternal acetaminophen use during pregnancy and childhood behavioural problems: Discrepancies between mother- and teacher-reported outcomes. Paediatric and Perinatal Epidemiology. PMID 31693212 DOI: 10.1111/ppe.12601  0.305
2019 Petersen JM, Parker SE, Benedum CM, Mitchell AA, Tinker SC, Werler MM. Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies. Birth Defects Research. PMID 31433116 DOI: 10.1002/Bdr2.1579  0.336
2019 Wachman EM, Saia K, Miller M, Valle E, Shrestha H, Carter G, Werler M, Jones H. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects. Clinical Therapeutics. PMID 31358302 DOI: 10.1016/J.Clinthera.2019.07.003  0.354
2019 Tinker SC, Reefhuis J, Bitsko RH, Gilboa SM, Mitchell AA, Tran EL, Werler MM, Broussard CS. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011. Birth Defects Research. PMID 30891943 DOI: 10.1002/Bdr2.1497  0.406
2018 Fisher SC, Van Zutphen AR, Werler MM, Romitti PA, Cunniff C, Browne ML. Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Research. PMID 30260586 DOI: 10.1002/bdr2.1372  0.379
2018 Dukhovny S, Van Bennekom CM, Gagnon DR, Hernandez Diaz S, Parker SE, Anderka M, Werler MM, Mitchell AA. Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study. Birth Defects Research. PMID 29388358 DOI: 10.1002/Bdr2.1199  0.302
2017 Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM. Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects. Annals of Epidemiology. PMID 29133009 DOI: 10.1016/J.Annepidem.2017.10.010  0.356
2017 Fisher SC, Van Zutphen AR, Werler MM, Lin AE, Romitti PA, Druschel CM, Browne ML. Maternal Antihypertensive Medication Use and Congenital Heart Defects: Updated Results From the National Birth Defects Prevention Study. Hypertension (Dallas, Tex. : 1979). PMID 28373593 DOI: 10.1161/Hypertensionaha.116.08773  0.362
2016 Brogly SB, Saia K, Hernández-Diaz S, Werler M, Sebastiani P. The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding? Addiction (Abingdon, England). 111: 2130-2131. PMID 28075537 DOI: 10.1111/Add.13551  0.423
2016 Getz KD, Anderka MT, Werler MM, Jick SS. Maternal Pre-pregnancy Body Mass Index and Autism Spectrum Disorder among Offspring: A Population-Based Case-Control Study. Paediatric and Perinatal Epidemiology. PMID 27239935 DOI: 10.1111/Ppe.12306  0.338
2016 Benedum CM, Yazdy MM, Parker SE, Mitchell AA, Werler MM. Association of Clomiphene and Assisted Reproductive Technologies With the Risk of Neural Tube Defects. American Journal of Epidemiology. PMID 27188944 DOI: 10.1093/aje/kwv322  0.345
2015 Brogly SB, Hahn KA, Diaz SH, Werler M. Confounding of the Comparative Safety of Prenatal Opioid Agonist Therapy. Journal of Addiction Research & Therapy. 6. PMID 27547489 DOI: 10.4172/2155-6105.1000252  0.343
2015 Parker SE, Gissler M, Ananth CV, Werler MM. Induced Abortions and the Risk of Preeclampsia Among Nulliparous Women. American Journal of Epidemiology. 182: 663-9. PMID 26377957 DOI: 10.1093/aje/kwv184  0.306
2015 Louik C, Werler M, Anderka M, Mitchell AA. Application of data screening to drug exposure in large risk factor studies of birth defects. Birth Defects Research. Part a, Clinical and Molecular Teratology. 103: 713-7. PMID 26259777 DOI: 10.1002/Bdra.23407  0.428
2015 Parker SE, Jick SS, Werler MM. Intrauterine device use and the risk of pre-eclampsia: a case-control study. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 25854682 DOI: 10.1111/1471-0528.13413  0.393
2015 Parker SE, Werler MM, Gissler M, Tikkanen M, Ananth CV. Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study. Paediatric and Perinatal Epidemiology. 29: 211-9. PMID 25761509 DOI: 10.1111/ppe.12184  0.36
2015 Vuong AM, Shinde MU, Brender JD, Shipp EM, Huber JC, Zheng Q, McDonald TJ, Sharkey JR, Hoyt AT, Werler MM, Kelley KE, Langlois PH, Canfield MA. Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age Births. Paediatric and Perinatal Epidemiology. 29: 60-71. PMID 25492517 DOI: 10.1111/Ppe.12169  0.375
2015 van Gelder MM, Van Bennekom CM, Louik C, Werler MM, Roeleveld N, Mitchell AA. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study. Bjog : An International Journal of Obstetrics and Gynaecology. 122: 1002-9. PMID 25395267 DOI: 10.1111/1471-0528.13138  0.448
2014 Ahrens KA, Louik C, Kerr S, Mitchell AA, Werler MM. Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth. Paediatric and Perinatal Epidemiology. 28: 498-509. PMID 25331380 DOI: 10.1111/Ppe.12152  0.56
2014 Parker SE, Starr JR, Collett BR, Speltz ML, Werler MM. Nausea and vomiting during pregnancy and neurodevelopmental outcomes in offspring. Paediatric and Perinatal Epidemiology. 28: 527-35. PMID 25327160 DOI: 10.1111/Ppe.12151  0.342
2014 Parker SE, Werler MM. Epidemiology of ischemic placental disease: a focus on preterm gestations. Seminars in Perinatology. 38: 133-8. PMID 24836824 DOI: 10.1053/j.semperi.2014.03.004  0.325
2014 Werler MM, Yazdy MM, Kasser JR, Mahan ST, Meyer RE, Anderka M, Druschel CM, Mitchell AA. Medication use in pregnancy in relation to the risk of isolated clubfoot in offspring. American Journal of Epidemiology. 180: 86-93. PMID 24824985 DOI: 10.1093/Aje/Kwu096  0.341
2014 Skuladottir H, Wilcox AJ, Ma C, Lammer EJ, Rasmussen SA, Werler MM, Shaw GM, Carmichael SL. Corticosteroid use and risk of orofacial clefts. Birth Defects Research. Part a, Clinical and Molecular Teratology. 100: 499-506. PMID 24777675 DOI: 10.1002/Bdra.23248  0.317
2014 Van Zutphen AR, Werler MM, Browne MM, Romitti PA, Bell EM, McNutt LA, Druschel CM, Mitchell AA. Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstetrics and Gynecology. 123: 309-17. PMID 24402588 DOI: 10.1097/Aog.0000000000000103  0.362
2013 Li Q, Mitchell AA, Werler MM, Yau WP, Hernández-Díaz S. Assessment of antihistamine use in early pregnancy and birth defects. The Journal of Allergy and Clinical Immunology. in Practice. 1: 666-74.e1. PMID 24565715 DOI: 10.1016/j.jaip.2013.07.008  0.382
2013 Benedum CM, Yazdy MM, Mitchell AA, Werler MM. Risk of spina bifida and maternal cigarette, alcohol, and coffee use during the first month of pregnancy. International Journal of Environmental Research and Public Health. 10: 3263-81. PMID 23917813 DOI: 10.3390/ijerph10083263  0.308
2013 Yau WP, Mitchell AA, Lin KJ, Werler MM, Hernández-Díaz S. Use of decongestants during pregnancy and the risk of birth defects. American Journal of Epidemiology. 178: 198-208. PMID 23825167 DOI: 10.1093/aje/kws427  0.362
2013 Ahrens KA, Anderka MT, Feldkamp ML, Canfield MA, Mitchell AA, Werler MM. Antiherpetic medication use and the risk of gastroschisis: Findings from the national birth defects prevention study, 1997-2007 Paediatric and Perinatal Epidemiology. 27: 340-345. PMID 23772935 DOI: 10.1111/Ppe.12064  0.576
2013 Werler MM, Yazdy MM, Mitchell AA, Meyer RE, Druschel CM, Anderka M, Kasser JR, Mahan ST. Descriptive epidemiology of idiopathic clubfoot. American Journal of Medical Genetics. Part A. 161: 1569-78. PMID 23686911 DOI: 10.1002/Ajmg.A.35955  0.367
2013 Lind JN, Tinker SC, Broussard CS, Reefhuis J, Carmichael SL, Honein MA, Olney RS, Parker SE, Werler MM. Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiology and Drug Safety. 22: 783-93. PMID 23620412 DOI: 10.1002/Pds.3448  0.38
2013 Van Bennekom CM, Mitchell AA, Moore CA, Werler MM. Vasoactive exposures during pregnancy and risk of microtia. Birth Defects Research. Part a, Clinical and Molecular Teratology. 97: 53-9. PMID 23180593 DOI: 10.1002/bdra.23101  0.339
2012 Parker SE, Werler MM, Shaw GM, Anderka M, Yazdy MM. Dietary glycemic index and the risk of birth defects. American Journal of Epidemiology. 176: 1110-20. PMID 23171874 DOI: 10.1093/Aje/Kws201  0.315
2012 Ahrens K, Lash TL, Louik C, Mitchell AA, Werler MM. Correcting for exposure misclassification using survival analysis with a time-varying exposure Annals of Epidemiology. 22: 799-806. PMID 23041654 DOI: 10.1016/J.Annepidem.2012.09.003  0.537
2012 Margulis AV, Mitchell AA, Gilboa SM, Werler MM, Mittleman MA, Glynn RJ, Hernandez-Diaz S. Use of topiramate in pregnancy and risk of oral clefts. American Journal of Obstetrics and Gynecology. 207: 405.e1-7. PMID 22917484 DOI: 10.1016/J.Ajog.2012.07.008  0.301
2012 Getz KD, Anderka MT, Werler MM, Case AP. Short interpregnancy interval and gastroschisis risk in the National Birth Defects Prevention Study. Birth Defects Research. Part a, Clinical and Molecular Teratology. 94: 714-20. PMID 22903973 DOI: 10.1002/Bdra.23061  0.41
2012 Al-Farsi YM, Brooks DR, Werler MM, Cabral HJ, Al-Shafaee MA, Wallenburg HC. Effect of high parity on occurrence of some fetal growth indices: a cohort study. International Journal of Women's Health. 4: 289-93. PMID 22870043 DOI: 10.2147/IJWH.S32190  0.349
2012 Yazdy MM, Tinker SC, Mitchell AA, Demmer LA, Werler MM. Maternal tea consumption during early pregnancy and the risk of spina bifida. Birth Defects Research. Part a, Clinical and Molecular Teratology. 94: 756-61. PMID 22641606 DOI: 10.1002/Bdra.23025  0.334
2012 Barger MK, Nannini A, Weiss J, Declercq ER, Stubblefield P, Werler M, Ringer S. Severe maternal and perinatal outcomes from uterine rupture among women at term with a trial of labor. Journal of Perinatology : Official Journal of the California Perinatal Association. 32: 837-43. PMID 22441115 DOI: 10.1038/Jp.2012.2  0.622
2012 Hernandez RK, Werler MM, Romitti P, Sun L, Anderka M. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. American Journal of Obstetrics and Gynecology. 206: 228.e1-8. PMID 22196851 DOI: 10.1016/J.Ajog.2011.11.019  0.355
2012 Anderka M, Mitchell AA, Louik C, Werler MM, Hernández-Diaz S, Rasmussen SA. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Research. Part a, Clinical and Molecular Teratology. 94: 22-30. PMID 22102545 DOI: 10.1002/Bdra.22865  0.349
2011 Brender JD, Werler MM, Kelley KE, Vuong AM, Shinde MU, Zheng Q, Huber JC, Sharkey JR, Griesenbeck JS, Romitti PA, Langlois PH, Suarez L, Canfield MA, The National Birth Defects Prevention Study. Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study. American Journal of Epidemiology. 174: 1286-95. PMID 22047825 DOI: 10.1093/Aje/Kwr254  0.316
2011 Werler MM, Ahrens KA, Bosco JLF, Mitchell AA, Anderka MT, Gilboa SM, Holmes LB. Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects Annals of Epidemiology. 21: 842-850. PMID 21982488 DOI: 10.1016/J.Annepidem.2011.08.002  0.61
2011 Barger MK, Weiss J, Nannini A, Werler M, Heeren T, Stubblefield PG. Risk factors for uterine rupture among women who attempt a vaginal birth after a previous cesarean: a case-control study. The Journal of Reproductive Medicine. 56: 313-20. PMID 21838161  0.634
2011 Gilboa SM, Broussard CS, Devine OJ, Duwe KN, Flak AL, Boulet SL, Moore CA, Werler MM, Honein MA. Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 157: 234-46. PMID 21766433 DOI: 10.1002/Ajmg.C.30306  0.344
2011 Ahrens K, Yazdy MM, Mitchell AA, Werler MM. Folic acid intake and spina bifida in the era of dietary folic acid fortification Epidemiology. 22: 731-737. PMID 21659881 DOI: 10.1097/Ede.0B013E3182227887  0.455
2011 Yazdy MM, Mitchell AA, Liu S, Werler MM. Maternal dietary glycaemic intake during pregnancy and the risk of birth defects. Paediatric and Perinatal Epidemiology. 25: 340-6. PMID 21649676 DOI: 10.1111/j.1365-3016.2011.01198.x  0.328
2011 Brender JD, Kelley KE, Werler MM, Langlois PH, Suarez L, Canfield MA. Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy. Birth Defects Research. Part a, Clinical and Molecular Teratology. 91: 258-64. PMID 21472845 DOI: 10.1002/Bdra.20808  0.334
2011 Al-Farsi YM, Brooks DR, Werler MM, Cabral HJ, Al-Shafei MA, Wallenburg HC. Effect of high parity on occurrence of anemia in pregnancy: a cohort study. Bmc Pregnancy and Childbirth. 11: 7. PMID 21251269 DOI: 10.1186/1471-2393-11-7  0.357
2010 Hernandez RK, Mitchell AA, Werler MM. Decongestant use during pregnancy and its association with preterm delivery. Birth Defects Research. Part a, Clinical and Molecular Teratology. 88: 715-21. PMID 20672347 DOI: 10.1002/Bdra.20699  0.396
2009 Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernández-Díaz S. Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction. Journal of Clinical Psychopharmacology. 29: 555-60. PMID 19910720 DOI: 10.1097/JCP.0b013e3181bf344c  0.367
2009 Werler MM, Mitchell AA, Moore CA, Honein MA. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? American Journal of Medical Genetics. Part A. 149: 1399-406. PMID 19533769 DOI: 10.1002/ajmg.a.32897  0.352
2009 Carmichael SL, Ma C, Werler MM, Olney RS, Shaw GM. Maternal corticosteroid use and hypospadias. The Journal of Pediatrics. 155: 39-44, 44.e1. PMID 19394038 DOI: 10.1016/J.Jpeds.2009.01.039  0.325
2009 Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Research. Part a, Clinical and Molecular Teratology. 85: 137-50. PMID 19161158 DOI: 10.1002/Bdra.20513  0.378
2009 Mosley BS, Cleves MA, Siega-Riz AM, Shaw GM, Canfield MA, Waller DK, Werler MM, Hobbs CA. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. American Journal of Epidemiology. 169: 9-17. PMID 18953063 DOI: 10.1093/Aje/Kwn331  0.323
2008 Nelson JW, Werler MM. Socioeconomic status as a modifier of the relationship between antibiotic use during pregnancy and birthweight. Birth (Berkeley, Calif.). 35: 196-203. PMID 18844645 DOI: 10.1111/J.1523-536X.2008.00240.X  0.346
2008 Petersen EE, Mitchell AA, Carey JC, Werler MM, Louik C, Rasmussen SA. Maternal exposure to statins and risk for birth defects: a case-series approach. American Journal of Medical Genetics. Part A. 146: 2701-5. PMID 18792975 DOI: 10.1002/ajmg.a.32493  0.334
2008 Bitsko RH, Reefhuis J, Louik C, Werler M, Feldkamp ML, Waller DK, Frias J, Honein MA. Periconceptional use of weight loss products including ephedra and the association with birth defects. Birth Defects Research. Part a, Clinical and Molecular Teratology. 82: 553-62. PMID 18553492 DOI: 10.1002/Bdra.20472  0.373
2008 Toh S, Mitchell AA, Werler MM, Hernández-Díaz S. Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception. American Journal of Epidemiology. 167: 633-40. PMID 18194999 DOI: 10.1093/aje/kwm367  0.321
2007 Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal corticosteroid use and orofacial clefts. American Journal of Obstetrics and Gynecology. 197: 585.e1-7; discussion. PMID 18060943 DOI: 10.1016/J.Ajog.2007.05.046  0.346
2007 Kabali C, Werler MM. Pre‐pregnant body mass index, weight gain and the risk of delivering large babies among non‐diabetic mothers International Journal of Gynecology & Obstetrics. 97: 100-104. PMID 17376448 DOI: 10.1016/J.Ijgo.2007.02.001  0.337
2007 Badovinac RL, Werler MM, Williams PL, Kelsey KT, Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Research. Part a, Clinical and Molecular Teratology. 79: 8-15. PMID 17133404 DOI: 10.1002/bdra.20315  0.332
2006 Werler MM. Teratogen update: pseudoephedrine. Birth Defects Research. Part a, Clinical and Molecular Teratology. 76: 445-52. PMID 16933214 DOI: 10.1002/BDRA.20255  0.391
2006 Louik C, Hernandez-Diaz S, Werler MM, Mitchell AA. Nausea and vomiting in pregnancy: maternal characteristics and risk factors. Paediatric and Perinatal Epidemiology. 20: 270-8. PMID 16879499 DOI: 10.1111/J.1365-3016.2006.00723.X  0.392
2006 Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. The New England Journal of Medicine. 354: 579-87. PMID 16467545 DOI: 10.1056/NEJMoa052744  0.325
2004 Cleves MA, Savell VH, Raj S, Zhao W, Correa A, Werler MM, Hobbs CA. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Research. Part a, Clinical and Molecular Teratology. 70: 107-13. PMID 15039924 DOI: 10.1002/Bdra.20005  0.363
2003 Meyer KA, Werler MM, Hayes C, Mitchell AA. Low maternal alcohol consumption during pregnancy and oral clefts in offspring: the Slone Birth Defects Study. Birth Defects Research. Part a, Clinical and Molecular Teratology. 67: 509-14. PMID 14565622 DOI: 10.1002/bdra.10057  0.335
2002 Hernández-Díaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. American Journal of Epidemiology. 156: 806-12. PMID 12396998 DOI: 10.1093/AJE/KWF129  0.398
2002 Louik C, Werler MM, Mitchell AA. Erythromycin use during pregnancy in relation to pyloric stenosis. American Journal of Obstetrics and Gynecology. 186: 288-90. PMID 11854652 DOI: 10.1067/MOB.2002.119718  0.38
2002 Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and risks of gastroschisis and small intestinal atresia. American Journal of Epidemiology. 155: 26-31. PMID 11772781 DOI: 10.1093/AJE/155.1.26  0.326
2001 Werler M. Additional Insights into the Etiology of Cardiac Anomalies Epidemiology. 12: 482-484. PMID 11505163 DOI: 10.1097/00001648-200109000-00003  0.427
2001 Bower C, Werler MM. Folate before pregnancy: are we doing enough? The Medical Journal of Australia. 174: 619-20. PMID 11480680 DOI: 10.5694/J.1326-5377.2001.TB143468.X  0.34
2001 Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. American Journal of Epidemiology. 153: 961-8. PMID 11384952 DOI: 10.1093/AJE/153.10.961  0.375
2001 Hernández-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects Obstetric and Gynecologic Survey. 56: 257-258. DOI: 10.1097/00006254-200105000-00005  0.388
2000 Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. The New England Journal of Medicine. 343: 1608-14. PMID 11096168 DOI: 10.1056/NEJM200011303432204  0.368
1999 Lieff S, Olshan AF, Werler M, Strauss RP, Smith J, Mitchell A. Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns American Journal of Epidemiology. 150: 683-694. PMID 10512422 DOI: 10.1093/Oxfordjournals.Aje.A010071  0.398
1992 Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology. 45: 361-7. PMID 1533958 DOI: 10.1002/TERA.1420450407  0.335
1992 Werler MM, Mitchell AA, Shapiro S. Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology. 45: 353-60. PMID 1533957 DOI: 10.1002/TERA.1420450406  0.394
1990 Werler MM, Lammer EJ, Rosenberg L, Mitchell AA. Maternal Cigarette Smoking During Pregnancy In Relation To Oral Clefts American Journal of Epidemiology. 132: 926-932. PMID 2239907 DOI: 10.1093/Oxfordjournals.Aje.A115735  0.303
1988 Louik C, Mitchell AA, Werler MM, Hanson JW, Shapiro S. "Maternal Exposure to Spermicides in Relation to Certain Birth Defects," Studies in Family Planning. 19: 66. DOI: 10.2307/1966744  0.32
1987 Louik C, Mitchell AA, Werler MM, Hanson JW, Shapiro S. Maternal exposure to spermicides in relation to certain birth defects. The New England Journal of Medicine. 317: 474-8. PMID 2956519 DOI: 10.1056/NEJM198708203170803  0.316
Show low-probability matches.